Plus Therapeutics Inc. (PSTV) reported a reduced loss for the first quarter compared to the previous year, surpassing Wall Street expectations.
The company posted a loss of $3.26 million, or $0.75 per share. This is an improvement from the loss of $4.81 million, or $2.07 per share, reported in the first quarter of last year.
Analysts, as surveyed by Thomson Reuters, had anticipated an average loss of $1.09 per share. These estimates generally exclude special items.
Revenue for the quarter saw a significant increase of 229.4%, rising to $1.68 million from $0.51 million in the prior year.
A summary of Plus Therapeutics Inc.'s first-quarter earnings (GAAP):
- Earnings (Q1): -$3.26 million compared to -$4.81 million last year.
- EPS (Q1): -$0.75 compared to -$2.07 last year.
- Revenue (Q1): $1.68 million compared to $0.51 million last year.